Guys, I need a side hustle o. Something that will be bringing me small money like N5k-N10k everyday. As I work full time, I can only spend like 2 hours a day on it. I DON’T want to do forex trading or Crypto. Let’s assume a seed capital of N1 million. Any ideas? #NaijaKnowledgeX

No one is going to do it for you

A thread...

As a founder, if you won't show up every single day, despite how you are feeling, or how the startup is doing or what the press is writing about you, or your cofounders not working out, or your product failing or your customers shouting

No one is going to do it for you

As a student, if you won't do things that scare you, that make you feel nervous, that challenge you, that intimidate you, that you have always wanted to do but never gathered the courage to

No one is going to do it for you

In your first job, if you are not going to make an effort to know how things have happened before and why, to meet new people, to seek help, to ask for feedback, to be patient with results, to not seek "impact" in the first month itself

No one is going to do it for you

If as a son/daughter you are not going to realize what your parents went through while growing up, that they want the same things from your life that you want for your self, that their path is different but there are reasons why

No one is going to do it for you

THREAD: The story of the week in finance is how a group of retail traders at @wallstreetbets, with assists from @ElonMusk and @Chamath, took down the establishment short sellers at GameStop.

A thread on the underlying mechanics of the $GME saga...

1/ First, for those unfamiliar with the business, GameStop is a videogame and merchandise retailer.

It has >5,000 stores, primarily in malls, across North America, Europe, and Australia.

The business has struggled to modernize, hurting its financial and stock performance.

2/ For a variety of business reasons, a bull (i.e. optimistic) case regarding its future performance has formed.

It really came to the forefront after RC Ventures, an entity managed by Chewy founder @ryancohen, disclosed a large position and assumed three board seats.

3/ @ryancohen summarized his case, stating:

"We are excited to bring our customer-obsessed mindset and technology experience to GameStop and its strategic assets...expanding the ways in which it delights customers and by becoming the ultimate destination for gamers."

4/ At the time of that statement on January 11, $GME stock was trading at about ~$20 per share.

Since then, the stock has surged to ~$200 per share and captured the public imagination.

But how did it happen?

There are two dynamics at play: a short squeeze and a gamma squeeze.

I just read all of Jeff Bezos's 23 letters to Amazon shareholders. And here's a thread with just one key-takeaway from each of these letters.

So if you're an artist or an entrepreneur looking to get some insight into the mind of this genius, read this right now.

1997: Focus relentlessly on your customers and long-term growth.

1998: Here are the 3 criteria Bezos wants managers to consider when hiring (to set the bar high):

1. Will you admire this person?

2. Will they raise the average level of effectiveness of the group?

3. Along what dimension might this person be a superstar?

1999: How to think long-term? Think: it's good enough today, but it will get so much better.

2000: "In the short run, the market is a voting machine but in the long run, it is a weighing machine.” - Benjamin Graham

We aren’t 10% smarter when the share goes 10% up, nor 10% dumber when it goes down. We want to be weighed, & we're always working to build a heavier company.

1. A company that has been brewing just outside our Top-5 for some time now is the electroporation (EP) company MaxCyte. Modelio assesses it as one of the best investments to capture the growing gene editing and gene therapy space, especially in allogeneic ex-vivo treatments.

2. We estimate that MaxCyte stands before a huge inflection point that will accelerate both growth and profitability. We have seen signs of the accelerating underlying activity by the fact that they in the last two years have added 9 of their 12 commercial agreements.

3. What makes MaxCyte unique compared to other “pick-and-shovel” businesses is their claim to milestones and royalties, something usually reserved for pharmaceutical companies.

4. As per the January update, MaxCyte has a potential pool of $950m in milestones, and a 2-3% (our estimates) of sales in royalties, that excludes licenses and consumables for the machines.

5. Reviewing the partners' pipelines, we think milestone revenues will unleash themselves in 2021 and beyond as they move further into clinical trials.